secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hims & Hers Health, Inc. (HIMS)
CIK:        0001773751
Form:       8-K
Filed at:   2023-02-27T23:59:59+00:00
Accession:  0001773751-23-000027
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hims & Hers Q4 revenue $167.2M (+97% YoY); achieves first positive adjusted EBITDA of $3.9M
--------------------------------------------------------------------------------

- Q4 revenue $167.2M, up 97% YoY; full year revenue $526.9M, up 94% YoY.
- Q4 net loss narrowed to $10.9M from $31.2M; adjusted EBITDA positive $3.9M (vs -$7.1M).
- Subscribers surpassed 1M (1.04M), up 88% YoY; monthly online revenue per subscriber $55.
- FY2023 guidance: revenue $735-755M, adjusted EBITDA $20-30M.
- Introduced 2025 targets: at least $1.2B revenue and $100M adjusted EBITDA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1773751/000177375123000027/0001773751-23-000027-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1773751/000177375123000027/hims-20230227.htm
  HTML page:      https://secwatch.observer/filing/0001773751-23-000027

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer